New Zealand markets closed

Ajanta Pharma Limited (AJANTPHARM.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
2,410.75-4.75 (-0.20%)
As of 11:06AM IST. Market open.
Currency in INR

Valuation measures4

Market cap (intra-day) 304.15B
Enterprise value 299.71B
Trailing P/E 37.35
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.24
Price/book (mrq)8.54
Enterprise value/revenue 7.13
Enterprise value/EBITDA 23.89

Trading information

Stock price history

Beta (5Y monthly) 0.03
52-week change 364.36%
S&P500 52-week change 322.70%
52-week high 32,531.95
52-week low 31,391.00
50-day moving average 32,283.39
200-day moving average 32,037.20

Share statistics

Avg vol (3-month) 35.7k
Avg vol (10-day) 34.92k
Shares outstanding 5125.92M
Implied shares outstanding 6125.92M
Float 842.28M
% held by insiders 166.42%
% held by institutions 122.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 436
Forward annual dividend yield 41.49%
Trailing annual dividend rate 336.00
Trailing annual dividend yield 31.49%
5-year average dividend yield 40.74
Payout ratio 455.58%
Dividend date 3N/A
Ex-dividend date 408 Feb 2024
Last split factor 21.5:1
Last split date 322 Jun 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 19.39%
Operating margin (ttm)23.16%

Management effectiveness

Return on assets (ttm)13.91%
Return on equity (ttm)23.47%

Income statement

Revenue (ttm)42.09B
Revenue per share (ttm)334.26
Quarterly revenue growth (yoy)19.50%
Gross profit (ttm)N/A
EBITDA 11.72B
Net income avi to common (ttm)8.16B
Diluted EPS (ttm)64.74
Quarterly earnings growth (yoy)65.80%

Balance sheet

Total cash (mrq)4.61B
Total cash per share (mrq)36.6
Total debt (mrq)352.8M
Total debt/equity (mrq)0.99%
Current ratio (mrq)3.05
Book value per share (mrq)283.32

Cash flow statement

Operating cash flow (ttm)7.85B
Levered free cash flow (ttm)1.14B